Dynavox Group
Dynavox Group AB (formerly Tobii Dynavox) is a Swedish medical technology company specializing in augmentative and alternative communication (AAC) solutions. The company designs, produces, and markets touch- and eye-tracking-based communication devices alongside specialized software. Key product lines include the Tobii Dynavox I-Series and TD Pilot, which enable speech-impaired individuals to communicate using eye movements or touch interfaces. Revenue is driven predominantly by hardware sales and software subscriptions, funded largely through healthcare reimbursement systems. Dynavox Group holds a world-leading market position in eye-gaze technology and assistive communication devices. The company is headquartered in Stockholm, Sweden, and its shares are listed on Nasdaq Stockholm.
44 of the funds FundTelligence covers report a position in Dynavox Group.
- Legal name
- Dynavox Group AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 44
Funds holding Dynavox Group
- Case Gaia Microcap — Case · 4.16 % (full portfolio disclosed, June 2026)
- Fondita Nordic Micro Cap — Fondita · 3.9 % (largest positions only, October 2026)
- Ruth Core Nordic Small Cap — Ruth · 3.84 % (largest positions only, September 2026)
- Cliens Sverige Fokus — Cliens · 3.6 % (largest positions only, October 2026)
- Nordea Innovation Sustainable Stars — Nordea Funds · 3.55 % (full portfolio disclosed, June 2026)
- Carnegie Global Resilient Small Cap — Carnegie · 3.35 % (full portfolio disclosed, June 2026)
- Case All Star Småbolag — Case · 3.22 % (full portfolio disclosed, June 2026)
- Lannebo Sweden Micro Cap — Lannebo · 2.93 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 44 funds holding it.